Clinical Trial: Blood Samples Were Taken From Patients Undergoing Oncological Treatment in Order to Validate the TST79 Molecular Test

U.S., Oct. 10 -- ClinicalTrials.gov registry received information related to the study (NCT07868640) titled 'Blood Samples Were Taken From Patients Undergoing Oncological Treatment in Order to Validate the TST79 Molecular Test' on Sept. 24.

Brief Summary: The pathological anatomy laboratory, which is managed by the IPG, would involve monitoring patients being treated for cancer and receiving care at the GHDC in order to take blood samples from those in whom the presence of plasma ctDNA carrying a mutation in a specific gene is suspected - a mutation detectable by the TST79 test.

Study Start Date: Sept. 15

Study Type: INTERVENTIONAL

Condition: Cancer

Intervention: GENETIC: Gene-alteration pair (G-A)

Point mutations, small insertions ...